• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于聚合酶链反应(PCR)的肽类抗生素FALL-39位点特异性诱变及其生物学活性

PCR-based site-specific mutagenesis of peptide antibiotics FALL-39 and its biologic activities.

作者信息

Yang Yun-xia, Feng Yun, Wang Bo-yao, Wu Qi

机构信息

Department of Pharmacology, West-China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu 610041, China.

出版信息

Acta Pharmacol Sin. 2004 Feb;25(2):239-45.

PMID:14769216
Abstract

AIM

To construct PGEX-1lambdaT-FALL-39 expression vector and its mutant vector, and study the relationship of function and structure.

METHODS

A cDNA encoding mature FALL-39 was cloned from SPCA-1 cell mRNA and the prokaryotic expression vector PGEX-1lambdaT-FALL-39 was constructed. Two kinds of polymerase chain reaction (PCR) for the site-direction mutagenesis were used to construct FALL-39 mutant expression vector, FALL-39-Lys-32 and FALL-39-Lys-24. Minimal effective concentration, minimal inhibitory concentration, and minimal bactericidal concentration were used to assay the antibacterial activities of these peptides. Effects of different solution on the antibacterial activity of FALL-39 and FALL-39-Lys-32 were observed by CFU determination. The hemolytic effects of these peptides were also examined on human red blood cells.

RESULTS

Two site-specific mutants FALL-39-Lys-32 and FALL-39-Lys24 were obtained by PCR-induced mutagenesis. In comparison with two-step PCR which required two pairs of primers, one step PCR which required one pair of primers is a simple and efficient method for the PCR based site-specific mutagenesis. Using the prokaryotic expression system, the E coli-based products of recombinant FALL39 and its mutant peptides were also obtained. The antibacterial assay showed that FALL-39-Lys-32 and FALL-39-Lys24 were more potential in the antibacterial activity against E coli ML35p and Pseudomonas aeruginosa ATCC27853 than that of FALL-39, and no increase in hemolysis was observed at the antibacterial concentrations. The antibacterial activity of FALL-39-Lys-32 against E coli was more potent than that of FALL-39 in NaCl-containing LB medium, while its activity was almost the same as FALL-39 in SO4(2-) containing Medium E.

CONCLUSION

PCR-based mutagenesis is a useful model system for studying the structure and function relationship of antimicrobial peptides. Keeping a-helical conformation of FALL-39 and increasing net positive charge can increase the antibacterial activity of FALL-39 without increasing hemolysis at the antibacterial concentrations.

摘要

目的

构建PGEX - 1λT - FALL - 39表达载体及其突变体载体,并研究其功能与结构的关系。

方法

从SPCA - 1细胞mRNA中克隆编码成熟FALL - 39的cDNA,构建原核表达载体PGEX - 1λT - FALL - 39。采用两种用于定点诱变的聚合酶链反应(PCR)构建FALL - 39突变体表达载体FALL - 39 - Lys - 32和FALL - 39 - Lys - 24。用最小有效浓度、最小抑菌浓度和最小杀菌浓度测定这些肽的抗菌活性。通过菌落形成单位(CFU)测定观察不同溶液对FALL - 39和FALL - 39 - Lys - 32抗菌活性的影响。还检测了这些肽对人红细胞的溶血作用。

结果

通过PCR诱导诱变获得了两个位点特异性突变体FALL - 39 - Lys - 32和FALL - 39 - Lys24。与需要两对引物的两步PCR相比,需要一对引物的一步PCR是基于PCR的定点诱变的一种简单有效的方法。利用原核表达系统,还获得了基于大肠杆菌的重组FALL39及其突变肽产物。抗菌试验表明,FALL - 39 - Lys - 32和FALL - 39 - Lys24对大肠杆菌ML35p和铜绿假单胞菌ATCC27853的抗菌活性比FALL - 39更强,且在抗菌浓度下未观察到溶血增加。在含NaCl的LB培养基中,FALL - 39 - Lys - 32对大肠杆菌的抗菌活性比FALL - 39更强,而在含SO4(2-)的培养基E中其活性与FALL - 39几乎相同。

结论

基于PCR的诱变是研究抗菌肽结构与功能关系的有用模型系统。保持FALL - 39的α - 螺旋构象并增加净正电荷可在不增加抗菌浓度下溶血的情况下提高FALL - 39的抗菌活性。

相似文献

1
PCR-based site-specific mutagenesis of peptide antibiotics FALL-39 and its biologic activities.基于聚合酶链反应(PCR)的肽类抗生素FALL-39位点特异性诱变及其生物学活性
Acta Pharmacol Sin. 2004 Feb;25(2):239-45.
2
[Construction of a site-directed mutant of FALL-39 and antibacterial activity of its E. coli-based product].[FALL-39定点突变体的构建及其基于大肠杆菌产物的抗菌活性]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2003 Jul;34(3):390-4.
3
[E. coli-based production of recombinant FALL-39].基于大肠杆菌的重组FALL-39的生产
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2003 Dec;20(4):634-7.
4
[E. coli-based production of recombinant HMG-17 and its antibacterial domain].基于大肠杆菌的重组HMG-17及其抗菌结构域的生产
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2005 Aug;22(4):773-7.
5
New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.来自胡蜂科黄蜂毒液的新型强效抗菌肽及其类似物。
Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.
6
Alpha-helical domain is essential for antimicrobial activity of high mobility group nucleosomal binding domain 2 (HMGN2).α-螺旋结构域对于高迁移率族核小体结合结构域2(HMGN2)的抗菌活性至关重要。
Acta Pharmacol Sin. 2005 Sep;26(9):1087-92. doi: 10.1111/j.1745-7254.2005.00132.x.
7
The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin.电荷和亲脂性对源自牛乳铁蛋白的十一肽抗菌活性的影响。
J Pept Sci. 2002 Jan;8(1):36-43. doi: 10.1002/psc.365.
8
Effects of Pro --> peptoid residue substitution on cell selectivity and mechanism of antibacterial action of tritrpticin-amide antimicrobial peptide.脯氨酸至类肽残基取代对三肽酰胺抗菌肽细胞选择性及抗菌作用机制的影响
Biochemistry. 2006 Oct 31;45(43):13007-17. doi: 10.1021/bi060487+.
9
A novel carrier molecule for high-level expression of peptide antibiotics in Escherichia coli.一种用于在大肠杆菌中高效表达肽抗生素的新型载体分子。
Protein Expr Purif. 2004 Jul;36(1):11-8. doi: 10.1016/j.pep.2004.01.020.
10
Expression and purification of a recombinant antibacterial peptide, cecropin, from Escherichia coli.从大肠杆菌中表达并纯化重组抗菌肽天蚕素
Protein Expr Purif. 2007 Jun;53(2):293-301. doi: 10.1016/j.pep.2006.12.020. Epub 2007 Jan 3.

引用本文的文献

1
Rational design of α-helical antimicrobial peptides to target Gram-negative pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: utilization of charge, 'specificity determinants,' total hydrophobicity, hydrophobe type and location as design parameters to improve the therapeutic ratio.靶向革兰氏阴性病原体,鲍曼不动杆菌和铜绿假单胞菌的α-螺旋抗菌肽的合理设计:利用电荷、“特异性决定簇”、总疏水性、疏水性类型和位置作为设计参数来提高治疗比率。
Chem Biol Drug Des. 2011 Apr;77(4):225-40. doi: 10.1111/j.1747-0285.2011.01086.x. Epub 2011 Feb 2.